Generics spending dropped $5.5 billion in the United States in 2017 due largely to competition and price decreases, according to the IQVIA Institute for Human Data Science report, Medicine Use and Spending in the U.S. A Review of 2017 and an Outlook to 2022.
Source: Drug Industry Daily